top of page

NaturalHealth365 on Weight Loss Drugs


(NaturalHealth365)  Surpassing the 40 percent mark, the current U.S. adult obesity rate has reached 42.4 percent, casting a glaring spotlight on the gravity of the nation’s obesity crisis.  Impressively, this signals a remarkable 26 percent surge in the national adult obesity rate since 2008.


As the obesity epidemic rages on, there’s a skyrocketing demand for weight loss medications.  Yet, the potential drawbacks of these drugs take center stage in a recent study featured in JAMA Network.  Adding to the complexity, these medications often come with a hefty price tag, and insurance coverage remains inconsistent.


 

Here is the title of the Journal of the American Medical Association publication:

Lewis Comment: Allow me to show you and example of what the word "rare" means within the medical industrial complex.



Is it possible that 350,000,000 could be labeled as rare? That is MORE than the entire population of the U.S.

 

NaturalHealth365 article continued..


GLP-1 agonists – Big Pharma’s financial triumph at the cost of personal health

The class of obesity drugs known as glucagon-like peptide-1 (GLP-1) agonists proves to be a financial triumph for Big Pharma.  However, these medications tread a delicate line, revealing a dual impact. 


Firstly, the weight loss drugs within the GLP-1 category come at a steep cost, presenting a financial burden for patients.  More significantly, the toll on personal health emerges as a substantial concern, as outlined below.


The extensive study referenced involved 4,144 individuals grappling with obesity, with a cohort opting for the brand-name weight loss drug Saxenda, also recognized as liraglutide.  Additionally, 613 participants took semaglutide, alternatively known as Rybelsus, Ozempic, and Wegovy, while another 654 were administered bupropion-naltrexone.


A myriad of side effects accompanies these weight loss drugs, including:

  • Thyroid complications with potential cancer implications

  • Signals for self-harm

  • Anesthesia-related complications

  • Impaired vision

  • A ninefold increase in the risk of pancreatitis, indicating pancreas inflammation

  • A fourfold greater risk for bowel obstruction


Note, we have a case of a 19yo on Ozempic whose gall bladder became inflamed and was surgically removed.


Moreover, long-term risks, potentially including cancer, loom on the horizon.  The widespread prescription of GLP-1 agonists for both weight loss and blood sugar regulation is prompting concerns within the medical community.  Despite mainstream media shedding light on the side effects of obesity medications, the demand for these drugs continues to surge.


Could Big Pharma’s financial maneuvers be a heist on ethical weight loss solutions?


In an alarming trend, manufacturers of Ozempic and Wegovy are engaging in ethically questionable practices by enticing American obesity doctors to prescribe their weight loss drugs.  While financial kickbacks from drugmakers to U.S. physicians have been prevalent for decades, the recent bribes from Big Pharma are particularly egregious in their moral implications.


For instance, Novo Nordisk has disbursed a staggering $25.8 million over the past decade in fees and expenses directly linked to weight loss drugs.  A significant portion of these funds was directed to a select group of obesity specialists who, in turn, advocated for the widespread use of these medications, impacting tens of millions of individuals across the United States.


The weight loss drug manufacturers have also allocated substantial sums for speaker fees, aiming to legitimize their medications and sway physicians into believing in their efficacy.  The additional expenditure on consulting fees to influence obesity specialists to promote these potentially perilous drugs to an unsuspecting population paints a picture akin to a heist, with ethical concerns reaching new heights.


Non-toxic weight loss strategies: 5 simple ways to combat the obesity epidemic

In the battle against the rising obesity epidemic, implementing small, manageable changes in daily life can yield significant health benefits.  Here are five practical tips to effortlessly incorporate into your routine:

  1. Mindful eating:  Take time to savor each bite, paying attention to hunger and fullness cues.  Minimize distractions during meals for a more mindful dining experience.  Chew your food well to improve digestion.

  2. Hydration habits:  Stay well-hydrated by drinking clean water throughout the day.  Adequate hydration can help prevent unnecessary snacking and support overall well-being.  Staying well hydrated will reduce your cravings.

  3. Balanced meals:  Prioritize balanced meals with a mix of nutrient-dense foods, including organic fruits, vegetables, and lean proteins.  Your health will improve greatly by eating colorful foods like dark leafy greens, cabbage and sea vegetables like wakame and nori.

  4. Regular physical activity:  Integrate regular physical activity into your day, whether through short walks, quick workouts, or other enjoyable exercises.  For added (social) benefits, exercise with friends or family.

  5. Smart snacking:  Choose healthier snack options like organic nuts, seeds and fruits.  Planning snacks in advance can help curb the temptation of less nutritious choices.


Remember, these changes need not be drastic; even small adjustments can collectively contribute to improved well-being.  Embracing these practices not only addresses the immediate challenge of obesity but also sets the stage for a sustainable, health-conscious future.  In an effort to help others, feel free to post your weight loss success stories below in the comment section.

Sources for this article include:

 

Previous blog on this topic.


Summary:


  • Most drugs are derived from nature.

  • Why not stick with nature?

  • Ozempic and related drugs are neurotoxins that shut down nervous system response

  • People on these drugs are experiencing SEVERE gut-related issues (but are in denial of the relationship because they are desperate to lose weight)

  • Vioxx killed an estimated 500,000 people AFTER it was approved as "safe and effective."

  • Is Ozempic the next drug to be withdrawn after too much damage has been done?


 

or click on the image below (the link above works best on phones)


















Here are slides from a recent presentation made to Ozempic users.


As healthcare spending goes UP - life expectancy goes DOWN. "Medical" drugs (pharmaceuticals) are a major cost driver.


Vioxx was approved as safe and effective and was on the market (killing people) for 5 years before it was withdrawn.

Sagely doctors take a "wait and see" attitude wrt new drugs because they know clinical trials are inadequate at elucidating true safety issues.


Do you or your loved ones want to be a guinea pig AGAIN?


My older brother, who will not take my advice, is on one of the new weight loss drugs. His blood pressure decreased from 140 to 110, and his heart rate from 75 to 46.


Is this natural for a 75-year-old who is unhealthy and obese? Is it possible for a drug to turn an old, fat, out-of-shape human into an Olympic athlete in 2 weeks?


Buyer beware!


 

Jodi just conveyed a story of a 19-year-old female prescribed Ozempic by her dermatologist father. Soon, she lost her gallbladder. They are in denial of any relationship.


Did you listen to Dr. Ardis? Do you see the correlation?

 

Weekly Webinar Links: Join us for detailed health information - at no charge. All are welcome.


Monday at noon EST -


Wednesday at 8 pm EST -

 


Be Bold - Be Brave - Stay Well




 

179 views0 comments

Recent Posts

See All

Comments


bottom of page